| Global Pharmaceuticals Research & Manufacturing |
| |
| 03-04 Dec 2008 Hotel J W Marriott |
| |
| • 寻找在印度进行临床实验外包的方法。 |
| • 世界上制药业界目前商业模式中，考虑印度研究制造业务委托服务（CRAMS）/医药品贩卖业务受托机关(CSO)优点活用的方法。 |
| • 针对将国际性的研究开发业务移转至印度的意义，进行讨论。 |
| • 检讨印度的医药品市场上的生物科技企业之影响力与贡献度。 |
| • 理解企业间的提携或协力之革新商业模式。 |
| |
| Key Note Speakers |
 |
|
 |
|
 |
|
 |
|
 |
Mr Suhas
Chaudhari
Joint
Commissioner
(Greater Mumbai)
FDA
Maharashtra State |
|
Mr Ranga Iyer
President OPPI and
Managing
Director
Wyeth |
|
Uma Nandan
Misra
Vice President
-Operations &
Site Manager
AstraZeneca Pharma |
|
Mr Ranjit Shahani
Vice Chairman
Managing
Director
and Country President
Novartis |
|
Mr Harjit
Singh
Senior
Development
Manager
Takeda Global Research
and
Development
UK |
|
| |
| |
| Top Level Speakers from |
| Abbott India |
Actis Biologics |
| All India Institute of
Medical Sciences |
Amgen India |
| AstraZeneca Pharma |
Aventis Pharma |
| Cadila Pharmaceuticals |
Dr Reddy's Laboratories |
| Eisai India |
Eli Lilly &Co. |
| Evolva Biotech |
FDA Maharashtra State |
| GlaxoSmithKline
Pharmaceuticals |
Institute of Clinical
Research India |
| Nishith Desai Associates |
Novartis |
| Nycomed Pharma USA |
Pfizer |
| Sandoz |
Takeda Global Research
and Development |
| USV |
Wockhardt |
| Wyeth |
Zydus Cadila |
|
| |
| 参加对象业界 |
• Pharmaceutical Companies |
• Biotech Companies |
• CROs and CMOs |
• Pharmaceutical Manufacturers |
• Research Laboratories and Institutes |
• Business Consulting Firms |
• Government Institutions and Regulators |
• Private Equity Funds |
• Venture Capitalists |
| |
| |
| 参加对象者 |
The Global Pharmaceuticals conference has been
developed with the following executives in mind: |
| • CXOs |
| • Project Directors |
| |
| |
